Therapeutic HIV Vaccines (for the HIV Positive)

Basics | News & Analysis | Research

Basics

AVAC's Introduction to AIDS Vaccines (Regularly Updated)
An interactive six-part online tutorial meant to educate individuals about the importance of vaccine research.
From AIDS Vaccine Advocacy Coalition
What Can We Expect From the First AIDS Vaccine? (May 18, 2007)
In San Francisco Chronicle
Therapeutic HIV Vaccines (May 2006)
To read PDF, click here.
From AIDSinfo
Therapeutic Vaccines -- Ready for Prime (and Boost) Time? (Winter 2004/2005)
An overview of recent research.
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Joining a Therapeutic HIV Vaccine Clinical Trial: Benefits and Risks (May 2004)
[Archived Article]
To read PDF, click here.
In WISE Words, from Project Inform
Therapeutic Vaccines (March 2002)
[Archived Article]
A potent weapon in the battle against HIV: your own immune system.
To read PDF, click here.
In Project Inform Perspective, from Project Inform
Therapeutic Immunization: A Vaccine by Any Other Name (Winter 2001/2002)
[Archived Article]
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
Status Report on HIV Vaccine Development (Winter 2000)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation

News & Analysis

An HIV/AIDS Vaccine Breakthrough? On CNN, Community Leaders Offer Perspective: A Blog Entry by Kellee Terrell (July 12, 2010)
From The Body
Scientists Closer Than Ever to AIDS Vaccine (July 11, 2010)
Longtime HIV-positive activists Phill Wilson of Black AIDS Institute and TheBody.com blogger Sherri Lewis speak about the recent discovery of three antibodies that neutralize most HIV strains.
From CNN.com
Georgia: AIDS Research Consortium of Atlanta Seeks Volunteers for Historic HIV Vaccine Trial (June 28, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
New Path to Therapeutic HIV Vaccine Discovered by Studying Immunologic Profile of Rare HIV Controllers (March 17, 2010)
Vacc-C5 to move from lab to phase I/II clinical trial.
To read PDF, click here.
From Bionor Immuno AS
Out of the Mouths of Babes: The Therapeutic Vaccine Question: A Blog Entry by Loreen Willenberg (March 9, 2010)
From The Body
The AIDS Institute, Nobel Prize Winner Join on World AIDS Day to Call for More Therapeutic Vaccine Funding (November 25, 2009)
From The AIDS Institute
Some Scientists Question Results of Recent HIV Vaccine Clinical Trial (October 12, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Researchers at HIV/AIDS Vaccine Conference Discuss New Methods, Ongoing Trials (October 20, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Personalized Cell Therapy for HIV: Good News or Useless News? (December 2004)
Mike Barr offers a more sobering look at ostensibly promising study results on a new therapeutic vaccine.
In TAGline, from Treatment Action Group
Single-Injection Therapeutic Vaccine Would Be Patient Dream -- and Pharma's Dread (March 2004)
[Archived Article]
In TAGline, from Treatment Action Group
Italian HIV Vaccine Trial Ready to Begin (June 5, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Botswana to Begin Trials for San Diego-Made AIDS Vaccine on Humans (May 20, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Expert Opinion From Barcelona: Vaccines (September/October 2002)
[Archived Article]
In Positively Aware, from Test Positive Aware Network

Research

Human Clinical Trials of HIV Vaccine to Start in January (December 21, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
VIRxSYS Vaccine "Functionally" Cures Two Monkeys in Recent Study (July 21, 2011)
From AIDSmeds.com
Promising New Research on Preventive and Therapeutic HIV Vaccines (May 24, 2011)
From Black AIDS Institute
Scientists Develop Nanovaccine Delivery Systems (February 23, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Personalized Vaccine Helps Decrease HIV Patients' Viral Load, Study Says (February 3, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
North Carolina: Duke to House HIV Vaccine Testing (November 24, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Further Analysis of Vacc-4x Phase IIb Study Shows a Statistically Significant Reduction in Viral Load Over Placebo (November 18, 2010)
Previous decision to put Vacc-4x on hold has been reversed.
From Bionor Pharma
AIDS 2010: Researchers Moving Toward HIV/AIDS Treatments and Cures (July 22, 2010)
From Black AIDS Institute
The Search for an HIV Vaccine: Where Are We, Where Are We Going, and How Can We Get There Faster? (July 18, 2010)
To read PDF, click here.
From Henry J. Kaiser Family Foundation
Discovery of Antibodies That Kill More Than 90% of HIV Viruses Gives New Hope for Vaccine (July 9, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
New Study Offers Clues for HIV Vaccine Development (May 6, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Salmonella, HIV Study May Help Researchers Better Understand How to Target HIV Vaccine (April 26, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Canada Cuts Off Funding to International AIDS Vaccine Project (April 1, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
UCLA Researchers Demonstrate That Stem Cells Can Be Engineered to Kill HIV (December 7, 2009)
Innovative strategy could be effective against other chronic viral diseases.
From University of California-Los Angeles
New Findings Suggest Strategy to Help Generate HIV-Neutralizing Antibodies (November 19, 2009)
From National Institute of Allergy and Infectious Diseases
NIAID Announces Vaccine Adjuvant Discovery Contracts (October 8, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
Discovery of Two Antibodies Could Move AIDS Vaccine Development Forward (September 4, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Transplant Drug Stimulates Immune Memory (June 22, 2009)
From Emory University
Clinical Trials in South Africa Help Fight HIV/AIDS (May 26, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Antibodies Present in Long-Term HIV Survivors Could Contribute to Vaccine Development, Study Says (March 17, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
HIV Vaccine Development in 2009: Looking Back (and Forward) (February 11, 2009)
Mitchell Warren, the top dog at the AIDS Vaccine Advocacy Coalition, talks about the current state of vaccine development. He explains why, in his opinion, hope on the vaccine front is far from lost.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Well-Armed Immune Cells Help Long-Term Non-Progressors Contain HIV (December 4, 2008)
From National Institute of Allergy and Infectious Diseases
Australia: New Immune Treatment May Control AIDS Virus (May 5, 2008)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
New Developments on Therapeutic Vaccines and Immune-Based Therapies for HIV Infection (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
HIV Vaccine's CD4+ Cell-Boosting Properties Lead Merck to Double Enrollment in Study (September 23, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
The Search Continues for a Therapeutic Vaccine (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Starting Anew (Again) (April 2003)
[Archived Article]
CROI 2003 updates on vaccines, siRNA therapy, CEM15 deactivation and the therapeutic value of GBV-C.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
HIV's Ability to Rapidly Evolve Occurs Quicker Than Thought (March 21, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Therapeutic Dendritic Cell Vaccine Lowers SIV Load (January/February 2003)
[Archived Article]
In TAGline, from Treatment Action Group
HIV's Success Might Lie in Its Mutations (November 6, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV-1 Superinfection: AE Subtype Supplanted by B Subtype (July 11, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
Immune Responses in Long-Term Non-Progressors -- Lessons for Immune Reconstitution (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
Therapeutic Vaccines (Summer/Autumn 2002)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Not to Be Sneezed At: Merck's HIV Vaccine Program (April 9, 2002)
[Archived Article]
Updates from Retrovirus 2002.
In TAGline, from Treatment Action Group
The Promise of New Vaccine Vectors, the Perils of Partial Protection (March 1, 2002)
[Archived Article]
Two new HIV vaccine studies published in the journal Nature.
In TAGline, from Treatment Action Group
Therapeutic Vaccinations (December 16, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
Vaccine Advance Underscores Need for Leadership (June 3, 1998)
[Archived Article]
From AIDS Action Council
Therapeutic Vaccines: the Return of Remune
[Archived Article]
In Reasons for Hope, from Search for a Cure